Sagent Pharmaceuticals' P2P Acquisition

Sagent Pharmaceuticals raised a round of funding on July 11, 2016. Investors include Nichi-Iko Pharmaceutical.

Sagent Pharmaceuticals is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectables. Sagent has c…

Articles about Sagent Pharmaceuticals' P2P Acquisition: